Department of Orthopaedics, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, China.
Department of Oethopaedics, Xinfeng County People's Hospital, Ganzhou, Jiangxi, China.
Front Immunol. 2024 Oct 9;15:1463078. doi: 10.3389/fimmu.2024.1463078. eCollection 2024.
OBJECT: Osteosarcoma is a malignant tumor originating from the bones, commonly found in children and adolescents, especially in rapidly growing bone areas such as the knees and upper arms. In this study, we aim to delineate the evolution and convergence of research themes in osteosarcoma metabolomics over the past decade, identify major contributors, and forecast emerging trends that could direct future research efforts. METHOD: The bibliometric method has been applied to systematically analyze the literature in the field of osteosarcoma metabolomics. The relevant literatures were collected from the Web of Science Core Collection, spanning from January 1, 2014, to December 31, 2023. Tools such as CiteSpace, Bibliometrix, and VOSviewer were used for the visual analysis of the collected literatures. The focused information includes institutions, journals, countries, authors, keywords, and citations. RESULT: Various aspects in the field of osteosarcoma metabolism were analyzed. Shanghai Jiao Tong University has published the most papers in the past ten years, followed by Central South University and Zhejiang University. Among the sources, the international journal of molecular sciences publishes the most articles, and oncotarget is the journal with the highest H index. According to Bradford's law, there are 34 core journals identified. A total of 5501 authors participated in the creation of papers in this field. The distribution of authors follows Lotka`s Law, and 85.3% of authors have only one article. 46% of the corresponding authors are from China, but most of these corresponding authors are not good at international cooperation. China also has the largest number of publications, followed by the United States. It can be confirmed that China dominates this field. Among the keywords, "expression" is the keyword that has received the most attention in the past ten years. All keywords can be divided into 9 clusters. Based on the explosive words and hot topics each year, we speculate that future research will focus on the tumor microenvironment, molecular mechanisms and autophagy, targeted therapies and inhibitors. CONCLUSION: In summary, this study comprehensively analyzed the current state of research in the field of osteosarcoma metabolism through bibliometric methods. The findings revealed the development trends and research hotspots in this field, which may provide valuable references for future research directions.
目的:骨肉瘤是一种起源于骨骼的恶性肿瘤,常见于儿童和青少年,特别是在膝关节和上臂等快速生长的骨区。在这项研究中,我们旨在描绘过去十年中骨肉瘤代谢组学研究主题的演变和趋同,确定主要贡献者,并预测可能指导未来研究工作的新兴趋势。
方法:应用文献计量学方法系统分析骨肉瘤代谢组学领域的文献。从 2014 年 1 月 1 日至 2023 年 12 月 31 日,从 Web of Science 核心合集收集相关文献。使用 CiteSpace、Bibliometrix 和 VOSviewer 等工具对收集的文献进行可视化分析。重点信息包括机构、期刊、国家、作者、关键词和引文。
结果:分析了骨肉瘤代谢领域的各个方面。上海交通大学在过去十年中发表的论文最多,其次是中南大学和浙江大学。在来源方面,国际期刊《分子科学杂志》发表的文章最多,《肿瘤靶向治疗》杂志的 H 指数最高。根据布拉德福定律,确定了 34 种核心期刊。共有 5501 名作者参与了该领域论文的创作。作者的分布遵循洛特卡定律,85.3%的作者只有一篇文章。46%的通讯作者来自中国,但这些通讯作者大多不善于国际合作。中国的出版物数量也最多,其次是美国。可以确认中国在该领域占据主导地位。在关键词中,“表达”是过去十年中最受关注的关键词。所有关键词可分为 9 个聚类。根据每年的爆发词和热门话题,我们推测未来的研究将集中在肿瘤微环境、分子机制和自噬、靶向治疗和抑制剂上。
结论:总之,本研究通过文献计量学方法全面分析了骨肉瘤代谢领域的研究现状。研究结果揭示了该领域的发展趋势和研究热点,为未来的研究方向提供了有价值的参考。
Front Endocrinol (Lausanne). 2023
Front Endocrinol (Lausanne). 2022
Front Biosci (Landmark Ed). 2022-9-29
J Cancer Res Clin Oncol. 2024-8-22
Endocr Metab Immune Disord Drug Targets. 2024
Front Aging Neurosci. 2025-5-14
Cancer Immunol Immunother. 2024-1-27
Front Immunol. 2023